US 11090361
Activin receptor type IIa variants and methods of use thereof
granted A61KA61K38/00A61K38/18
Quick answer
US patent 11090361 (Activin receptor type IIa variants and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Keros Therapeutics, Inc.
- Grant date
- Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K38/18, A61K47/64, A61K47/65